+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Renal Denervation Market By Product Type, By Technology, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030

  • PDF Icon

    Report

  • 195 Pages
  • March 2022
  • Region: Global
  • Allied Market Research
  • ID: 5640538
Description Jump to:
The global renal denervation market size was valued at $156,327.4 thousand in 2020, and is projected to reach $4,555,983.0 thousand by 2030, registering a CAGR of 40.7% from 2021 to 2030.Renal denervation is a catheter-based minimally invasive therapy used to treat hypertension in patients. Renal denervation is usually used when other treatments have failed to relieve the patient's symptoms. The renal artery wall nerves are ablated with ultrasound or radio frequency pulses in this operation. Hence, ultrasound renal denervation helps in reducing blood pressure in patient with hypertension.

The renal denervation market has grown owning to excessive alcohol consumption, lack of physical exercises &activities, smoking, and fast-food consumption all contribute to an increased risk of hypertension. Further, it causes various disorders, such as heart attacks, stroke, pulmonary arterial hypertension, and also cause high blood pressure. As a result, during the forecast period, such factor is expected to create growth opportunity for renal denervation system for treating hypertension and other diseases.

Furthermore, there is large number of renal denervation devices, which are manufactured by major key players in the market to treat hypertension and other diseases. For instance, in November 2021, Medtronic Plc, manufacturer of medical devices and technologies announced Spyral Affirm study evaluating safety, durability of Symplicity renal denervation system to control hypertension and other disorder such as diabetes, chronic kidney disease, and isolated systolic hypertension.

The market is segmented on the basis of product, technology, and geography. On the basis of product, the market is divided into symplicity, enligHTN, vessix, paradise, and iberis. On the basis of technology, the market is divided into radiofrequency, ultrasound, and micro-infusion. On the basis of end user, the market is divided into hospitals, specialty clinics, and others. Region wise, the market analysis is conducted across North America (the U.S., Canada, and Mexico), Europe (the UK, France, Germany, Italy, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).

Competition Analysis


The key players that operate in the global renal denervation are Ablative Solutions, Inc., Abbott Laboratories, Johnson & Johnson, Cardiosonic Ltd, Boston Scientific Corporation, Medtronic plc, Mercator MedSystems, Inc., ReCor Medical, Inc., Renal Dynamics Limited, and Terumo Corporation.

Key Benefits For Stakeholders

  • The report provides an extensive analysis of the current and emerging renal denervation market trends and dynamics.
  • In-depth renal denervation market analysis is conducted by constructing market estimations for key market segments between 2021 and 2030.
  • Extensive analysis of the renal denervation market growth is conducted by following key product positioning and monitoring of top competitors within the market framework.
  • The report includes renal denervation market opportunity.
  • The global renal denervation market forecast analysis from 2021 to 2030 is included in the report.
  • The key players within renal denervation market are profiled in this report and their strategies are analyzed thoroughly, which help understand the competitive outlook of the renal denervation industry.

Key Market Segments


BY PRODUCT TYPE

  • Symplicity
  • Enlightn
  • Vessix
  • Paradise
  • Iberis
  • Others

BY TECHNOLOGY

  • Radiofrequency
  • Ultrasound
  • Micro-Infusion

BY END USER

  • Hospitals
  • Specialty Clinics
  • Others

BY REGION

  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Rest of Europe
  • LAMEA
  • Latin America
  • Middle East
  • Africa
  • North America
  • U.S.
  • Canada
  • Mexico

Key Market Players

  • Ablative Solutions, Inc
  • Abbott Laboratories
  • Johnson & Johnson
  • Cardiosonic Ltd
  • Boston Scientific Corporation
  • Medtronic plc
  • Mercator MedSystems, Inc
  • ReCor Medical, Inc
  • Renal Dynamics Limited
  • terumo corporation

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: RENAL DENERVATION MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Symplicity
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Enlightn
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Vessix
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Paradise
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Iberis
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Others
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
CHAPTER 5: RENAL DENERVATION MARKET, BY TECHNOLOGY
5.1 Overview
5.1.1 Market size and forecast
5.2 Radiofrequency
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Ultrasound
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Micro-Infusion
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: RENAL DENERVATION MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Specialty Clinics
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: RENAL DENERVATION MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 Asia-Pacific
7.2.1 Key trends and opportunities
7.2.2 Asia-Pacific Market size and forecast, by Product Type
7.2.3 Asia-Pacific Market size and forecast, by Technology
7.2.4 Asia-Pacific Market size and forecast, by End User
7.2.5 Asia-Pacific Market size and forecast, by country
7.2.5.1 China
7.2.5.1.1 Market size and forecast, by Product Type
7.2.5.1.2 Market size and forecast, by Technology
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 India
7.2.5.2.1 Market size and forecast, by Product Type
7.2.5.2.2 Market size and forecast, by Technology
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Japan
7.2.5.3.1 Market size and forecast, by Product Type
7.2.5.3.2 Market size and forecast, by Technology
7.2.5.3.3 Market size and forecast, by End User
7.2.5.4 Australia
7.2.5.4.1 Market size and forecast, by Product Type
7.2.5.4.2 Market size and forecast, by Technology
7.2.5.4.3 Market size and forecast, by End User
7.2.5.5 Rest of Asia-Pacific
7.2.5.5.1 Market size and forecast, by Product Type
7.2.5.5.2 Market size and forecast, by Technology
7.2.5.5.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product Type
7.3.3 Europe Market size and forecast, by Technology
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product Type
7.3.5.1.2 Market size and forecast, by Technology
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product Type
7.3.5.2.2 Market size and forecast, by Technology
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 U.K.
7.3.5.3.1 Market size and forecast, by Product Type
7.3.5.3.2 Market size and forecast, by Technology
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Product Type
7.3.5.4.2 Market size and forecast, by Technology
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Rest of Europe
7.3.5.5.1 Market size and forecast, by Product Type
7.3.5.5.2 Market size and forecast, by Technology
7.3.5.5.3 Market size and forecast, by End User
7.4 LAMEA
7.4.1 Key trends and opportunities
7.4.2 LAMEA Market size and forecast, by Product Type
7.4.3 LAMEA Market size and forecast, by Technology
7.4.4 LAMEA Market size and forecast, by End User
7.4.5 LAMEA Market size and forecast, by country
7.4.5.1 Latin America
7.4.5.1.1 Market size and forecast, by Product Type
7.4.5.1.2 Market size and forecast, by Technology
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 Middle East
7.4.5.2.1 Market size and forecast, by Product Type
7.4.5.2.2 Market size and forecast, by Technology
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 Africa
7.4.5.3.1 Market size and forecast, by Product Type
7.4.5.3.2 Market size and forecast, by Technology
7.4.5.3.3 Market size and forecast, by End User
7.5 North America
7.5.1 Key trends and opportunities
7.5.2 North America Market size and forecast, by Product Type
7.5.3 North America Market size and forecast, by Technology
7.5.4 North America Market size and forecast, by End User
7.5.5 North America Market size and forecast, by country
7.5.5.1 U.S.
7.5.5.1.1 Market size and forecast, by Product Type
7.5.5.1.2 Market size and forecast, by Technology
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Canada
7.5.5.2.1 Market size and forecast, by Product Type
7.5.5.2.2 Market size and forecast, by Technology
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 Mexico
7.5.5.3.1 Market size and forecast, by Product Type
7.5.5.3.2 Market size and forecast, by Technology
7.5.5.3.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Ablative Solutions, Inc
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Abbott Laboratories
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Johnson & Johnson
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Cardiosonic Ltd
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Boston Scientific Corporation
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Medtronic plc
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Mercator MedSystems, Inc
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 ReCor Medical, Inc
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Renal Dynamics Limited
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 terumo corporation
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
LIST OF TABLES
Table 1. Global Renal Denervation Market, by Product Type, 2020-2030, ($Thousand)
Table 2. Renal Denervation Market Revenue, for Symplicity, by Region, 2020-2030, ($Thousand)
Table 3. Renal Denervation Market Symplicity by Country, 2020-2030, ($Thousand)
Table 4. Renal Denervation Market Revenue, for Enlightn, by Region, 2020-2030, ($Thousand)
Table 5. Renal Denervation Market Enlightn by Country, 2020-2030, ($Thousand)
Table 6. Renal Denervation Market Revenue, for Vessix, by Region, 2020-2030, ($Thousand)
Table 7. Renal Denervation Market Vessix by Country, 2020-2030, ($Thousand)
Table 8. Renal Denervation Market Revenue, for Paradise, by Region, 2020-2030, ($Thousand)
Table 9. Renal Denervation Market Paradise by Country, 2020-2030, ($Thousand)
Table 10. Renal Denervation Market Revenue, for Iberis, by Region, 2020-2030, ($Thousand)
Table 11. Renal Denervation Market Iberis by Country, 2020-2030, ($Thousand)
Table 12. Renal Denervation Market Revenue, for Others, by Region, 2020-2030, ($Thousand)
Table 13. Renal Denervation Market Others by Country, 2020-2030, ($Thousand)
Table 14. Global Renal Denervation Market, by Technology, 2020-2030, ($Thousand)
Table 15. Renal Denervation Market Revenue, for Radiofrequency, by Region, 2020-2030, ($Thousand)
Table 16. Renal Denervation Market Radiofrequency by Country, 2020-2030, ($Thousand)
Table 17. Renal Denervation Market Revenue, for Ultrasound, by Region, 2020-2030, ($Thousand)
Table 18. Renal Denervation Market Ultrasound by Country, 2020-2030, ($Thousand)
Table 19. Renal Denervation Market Revenue, for Micro-Infusion, by Region, 2020-2030, ($Thousand)
Table 20. Renal Denervation Market Micro-Infusion by Country, 2020-2030, ($Thousand)
Table 21. Global Renal Denervation Market, by End-user, 2020-2030, ($Thousand)
Table 22. Renal Denervation Market Revenue, for Hospitals, by Region, 2020-2030, ($Thousand)
Table 23. Renal Denervation Market Hospitals by Country, 2020-2030, ($Thousand)
Table 24. Renal Denervation Market Revenue, for Specialty Clinics, by Region, 2020-2030, ($Thousand)
Table 25. Renal Denervation Market Specialty Clinics by Country, 2020-2030, ($Thousand)
Table 26. Renal Denervation Market Revenue, for Others, by Region, 2020-2030, ($Thousand)
Table 27. Renal Denervation Market Others by Country, 2020-2030, ($Thousand)
Table 28. Renal Denervation Market, by Region, 2020-2030, ($Thousand)
Table 29. Asia-Pacific Renal Denervation Market, by Product Type, 2020-2030, ($Thousand)
Table 30. Asia-Pacific Renal Denervation Market, by Technology, 2020-2030, ($Thousand)
Table 31. Asia-Pacific Renal Denervation Market, by End-user, 2020-2030, ($Thousand)
Table 32. Asia-Pacific Renal Denervation Market, by Country, 2020-2030, ($Thousand)
Table 33. China Renal Denervation Market by Product Type 2020-2030, ($Thousand)
Table 34. China Renal Denervation Market by Technology 2020-2030, ($Thousand)
Table 35. China Renal Denervation Market by End-user 2020-2030, ($Thousand)
Table 36. India Renal Denervation Market by Product Type 2020-2030, ($Thousand)
Table 37. India Renal Denervation Market by Technology 2020-2030, ($Thousand)
Table 38. India Renal Denervation Market by End-user 2020-2030, ($Thousand)
Table 39. Japan Renal Denervation Market by Product Type 2020-2030, ($Thousand)
Table 40. Japan Renal Denervation Market by Technology 2020-2030, ($Thousand)
Table 41. Japan Renal Denervation Market by End-user 2020-2030, ($Thousand)
Table 42. Australia Renal Denervation Market by Product Type 2020-2030, ($Thousand)
Table 43. Australia Renal Denervation Market by Technology 2020-2030, ($Thousand)
Table 44. Australia Renal Denervation Market by End-user 2020-2030, ($Thousand)
Table 45. Rest of Asia-Pacific Renal Denervation Market by Product Type 2020-2030, ($Thousand)
Table 46. Rest of Asia-Pacific Renal Denervation Market by Technology 2020-2030, ($Thousand)
Table 47. Rest of Asia-Pacific Renal Denervation Market by End-user 2020-2030, ($Thousand)
Table 48. Europe Renal Denervation Market, by Product Type, 2020-2030, ($Thousand)
Table 49. Europe Renal Denervation Market, by Technology, 2020-2030, ($Thousand)
Table 50. Europe Renal Denervation Market, by End-user, 2020-2030, ($Thousand)
Table 51. Europe Renal Denervation Market, by Country, 2020-2030, ($Thousand)
Table 52. Germany Renal Denervation Market by Product Type 2020-2030, ($Thousand)
Table 53. Germany Renal Denervation Market by Technology 2020-2030, ($Thousand)
Table 54. Germany Renal Denervation Market by End-user 2020-2030, ($Thousand)
Table 55. France Renal Denervation Market by Product Type 2020-2030, ($Thousand)
Table 56. France Renal Denervation Market by Technology 2020-2030, ($Thousand)
Table 57. France Renal Denervation Market by End-user 2020-2030, ($Thousand)
Table 58. U.K. Renal Denervation Market by Product Type 2020-2030, ($Thousand)
Table 59. U.K. Renal Denervation Market by Technology 2020-2030, ($Thousand)
Table 60. U.K. Renal Denervation Market by End-user 2020-2030, ($Thousand)
Table 61. Italy Renal Denervation Market by Product Type 2020-2030, ($Thousand)
Table 62. Italy Renal Denervation Market by Technology 2020-2030, ($Thousand)
Table 63. Italy Renal Denervation Market by End-user 2020-2030, ($Thousand)
Table 64. Rest of Europe Renal Denervation Market by Product Type 2020-2030, ($Thousand)
Table 65. Rest of Europe Renal Denervation Market by Technology 2020-2030, ($Thousand)
Table 66. Rest of Europe Renal Denervation Market by End-user 2020-2030, ($Thousand)
Table 67. LAMEA Renal Denervation Market, by Product Type, 2020-2030, ($Thousand)
Table 68. LAMEA Renal Denervation Market, by Technology, 2020-2030, ($Thousand)
Table 69. LAMEA Renal Denervation Market, by End-user, 2020-2030, ($Thousand)
Table 70. LAMEA Renal Denervation Market, by Country, 2020-2030, ($Thousand)
Table 71. Latin America Renal Denervation Market by Product Type 2020-2030, ($Thousand)
Table 72. Latin America Renal Denervation Market by Technology 2020-2030, ($Thousand)
Table 73. Latin America Renal Denervation Market by End-user 2020-2030, ($Thousand)
Table 74. Middle East Renal Denervation Market by Product Type 2020-2030, ($Thousand)
Table 75. Middle East Renal Denervation Market by Technology 2020-2030, ($Thousand)
Table 76. Middle East Renal Denervation Market by End-user 2020-2030, ($Thousand)
Table 77. Africa Renal Denervation Market by Product Type 2020-2030, ($Thousand)
Table 78. Africa Renal Denervation Market by Technology 2020-2030, ($Thousand)
Table 79. Africa Renal Denervation Market by End-user 2020-2030, ($Thousand)
Table 80. North America Renal Denervation Market, by Product Type, 2020-2030, ($Thousand)
Table 81. North America Renal Denervation Market, by Technology, 2020-2030, ($Thousand)
Table 82. North America Renal Denervation Market, by End-user, 2020-2030, ($Thousand)
Table 83. North America Renal Denervation Market, by Country, 2020-2030, ($Thousand)
Table 84. U.S. Renal Denervation Market by Product Type 2020-2030, ($Thousand)
Table 85. U.S. Renal Denervation Market by Technology 2020-2030, ($Thousand)
Table 86. U.S. Renal Denervation Market by End-user 2020-2030, ($Thousand)
Table 87. Canada Renal Denervation Market by Product Type 2020-2030, ($Thousand)
Table 88. Canada Renal Denervation Market by Technology 2020-2030, ($Thousand)
Table 89. Canada Renal Denervation Market by End-user 2020-2030, ($Thousand)
Table 90. Mexico Renal Denervation Market by Product Type 2020-2030, ($Thousand)
Table 91. Mexico Renal Denervation Market by Technology 2020-2030, ($Thousand)
Table 92. Mexico Renal Denervation Market by End-user 2020-2030, ($Thousand)
Table 93. Ablative Solutions, Inc: Company Snapshot
Table 94. Ablative Solutions, Inc: Operating Segments
Table 95. Ablative Solutions, Inc: Product Portfolio
Table 96. Ablative Solutions, Inc: Net Sales
Table 97. Ablative Solutions, Inc: Key Stratergies
Table 98. Abbott Laboratories: Company Snapshot
Table 99. Abbott Laboratories: Operating Segments
Table 100. Abbott Laboratories: Product Portfolio
Table 101. Abbott Laboratories: Net Sales
Table 102. Abbott Laboratories: Key Stratergies
Table 103. Johnson & Johnson: Company Snapshot
Table 104. Johnson & Johnson: Operating Segments
Table 105. Johnson & Johnson: Product Portfolio
Table 106. Johnson & Johnson: Net Sales
Table 107. Johnson & Johnson: Key Stratergies
Table 108. Cardiosonic Ltd: Company Snapshot
Table 109. Cardiosonic Ltd: Operating Segments
Table 110. Cardiosonic Ltd: Product Portfolio
Table 111. Cardiosonic Ltd: Net Sales
Table 112. Cardiosonic Ltd: Key Stratergies
Table 113. Boston Scientific Corporation: Company Snapshot
Table 114. Boston Scientific Corporation: Operating Segments
Table 115. Boston Scientific Corporation: Product Portfolio
Table 116. Boston Scientific Corporation: Net Sales
Table 117. Boston Scientific Corporation: Key Stratergies
Table 118. Medtronic plc: Company Snapshot
Table 119. Medtronic plc: Operating Segments
Table 120. Medtronic plc: Product Portfolio
Table 121. Medtronic plc: Net Sales
Table 122. Medtronic plc: Key Stratergies
Table 123. Mercator Medsystems, Inc: Company Snapshot
Table 124. Mercator Medsystems, Inc: Operating Segments
Table 125. Mercator Medsystems, Inc: Product Portfolio
Table 126. Mercator Medsystems, Inc: Net Sales
Table 127. Mercator Medsystems, Inc: Key Stratergies
Table 128. Recor Medical, Inc: Company Snapshot
Table 129. Recor Medical, Inc: Operating Segments
Table 130. Recor Medical, Inc: Product Portfolio
Table 131. Recor Medical, Inc: Net Sales
Table 132. Recor Medical, Inc: Key Stratergies
Table 133. Renal Dynamics Limited: Company Snapshot
Table 134. Renal Dynamics Limited: Operating Segments
Table 135. Renal Dynamics Limited: Product Portfolio
Table 136. Renal Dynamics Limited: Net Sales
Table 137. Renal Dynamics Limited: Key Stratergies
Table 138. Terumo Corporation: Company Snapshot
Table 139. Terumo Corporation: Operating Segments
Table 140. Terumo Corporation: Product Portfolio
Table 141. Terumo Corporation: Net Sales
Table 142. Terumo Corporation: Key Stratergies
LIST OF FIGURES
Figure 1. Renal Denervation Market Segmentation
Figure 2. Renal Denervation Market, 2020-2030
Figure 3. Renal Denervation Market, 2020-2030
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Renal Denervation Market:Drivers, Restraints and Opportunities
Figure 11. Renal Denervation Market, by Product Type, 2020 (%)
Figure 12. Comparative Share Analysis of Symplicity Renal Denervation Market, 2020-2030 (%)
Figure 13. Comparative Share Analysis of Enlightn Renal Denervation Market, 2020-2030 (%)
Figure 14. Comparative Share Analysis of Vessix Renal Denervation Market, 2020-2030 (%)
Figure 15. Comparative Share Analysis of Paradise Renal Denervation Market, 2020-2030 (%)
Figure 16. Comparative Share Analysis of Iberis Renal Denervation Market, 2020-2030 (%)
Figure 17. Comparative Share Analysis of Others Renal Denervation Market, 2020-2030 (%)
Figure 18. Renal Denervation Market, by Technology, 2020 (%)
Figure 19. Comparative Share Analysis of Radiofrequency Renal Denervation Market, 2020-2030 (%)
Figure 20. Comparative Share Analysis of Ultrasound Renal Denervation Market, 2020-2030 (%)
Figure 21. Comparative Share Analysis of Micro-Infusion Renal Denervation Market, 2020-2030 (%)
Figure 22. Renal Denervation Market, by End-user, 2020 (%)
Figure 23. Comparative Share Analysis of Hospitals Renal Denervation Market, 2020-2030 (%)
Figure 24. Comparative Share Analysis of Specialty Clinics Renal Denervation Market, 2020-2030 (%)
Figure 25. Comparative Share Analysis of Others Renal Denervation Market, 2020-2030 (%)
Figure 26. Renal Denervation Market by Region, 2020
Figure 27. China Renal Denervation Market, 2020-2030 ($Thousand)
Figure 28. India Renal Denervation Market, 2020-2030 ($Thousand)
Figure 29. Japan Renal Denervation Market, 2020-2030 ($Thousand)
Figure 30. Australia Renal Denervation Market, 2020-2030 ($Thousand)
Figure 31. Rest of Asia-Pacific Renal Denervation Market, 2020-2030 ($Thousand)
Figure 32. Germany Renal Denervation Market, 2020-2030 ($Thousand)
Figure 33. France Renal Denervation Market, 2020-2030 ($Thousand)
Figure 34. U.K. Renal Denervation Market, 2020-2030 ($Thousand)
Figure 35. Italy Renal Denervation Market, 2020-2030 ($Thousand)
Figure 36. Rest of Europe Renal Denervation Market, 2020-2030 ($Thousand)
Figure 37. Latin America Renal Denervation Market, 2020-2030 ($Thousand)
Figure 38. Middle East Renal Denervation Market, 2020-2030 ($Thousand)
Figure 39. Africa Renal Denervation Market, 2020-2030 ($Thousand)
Figure 40. U.S. Renal Denervation Market, 2020-2030 ($Thousand)
Figure 41. Canada Renal Denervation Market, 2020-2030 ($Thousand)
Figure 42. Mexico Renal Denervation Market, 2020-2030 ($Thousand)
Figure 43. Top Winning Strategies, by Year
Figure 44. Top Winning Strategies, by Development
Figure 45. Top Winning Strategies, by Company
Figure 46. Product Mapping of Top 10 Players
Figure 47. Competitive Dashboard
Figure 48. Competitive Heatmap of Top 10 Key Players
Figure 49. Ablative Solutions, Inc.: Net Sales, ($Thousand)
Figure 50. Abbott Laboratories.: Net Sales, ($Thousand)
Figure 51. Johnson & Johnson.: Net Sales, ($Thousand)
Figure 52. Cardiosonic Ltd.: Net Sales, ($Thousand)
Figure 53. Boston Scientific Corporation.: Net Sales, ($Thousand)
Figure 54. Medtronic PLC.: Net Sales, ($Thousand)
Figure 55. Mercator Medsystems, Inc.: Net Sales, ($Thousand)
Figure 56. Recor Medical, Inc.: Net Sales, ($Thousand)
Figure 57. Renal Dynamics Limited.: Net Sales, ($Thousand)
Figure 58. Terumo Corporation.: Net Sales, ($Thousand)

Companies Mentioned

  • Ablative Solutions, Inc
  • Abbott Laboratories
  • Johnson & Johnson
  • Cardiosonic Ltd
  • Boston Scientific Corporation
  • Medtronic plc
  • Mercator MedSystems, Inc
  • ReCor Medical, Inc
  • Renal Dynamics Limited
  • terumo corporation

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages195
PublishedMarch 2022
Forecast Period2020 - 2030
Estimated Market Value ( USD ) in 2020 $ 156327.4 thousand
Forecasted Market Value ( USD ) by 2030 $ 4555983 thousand
Compound Annual Growth Rate40.1%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Renal Denervation Devices Market by Technology (Micro-Infusion-Based, Pharmacologic Ablation, Radiofrequency-Based), Products (Catheters, Nerve Modifying Agents, RF Generator), Disease Application, End-User - Forecast 2023-2030 - Product Image

Global Renal Denervation Devices Market by Technology (Micro-Infusion-Based, Pharmacologic Ablation, Radiofrequency-Based), Products (Catheters, Nerve Modifying Agents, RF Generator), Disease Application, End-User - Forecast 2023-2030

  • Report
  • 187 Pages
  • Global
From
Renal Denervation Technologies - Global Strategic Business Report - Product Image

Renal Denervation Technologies - Global Strategic Business Report

  • Report
  • 107 Pages
  • Global
From
Renal Denervation Devices Global Market Report 2024 - Product Image

Renal Denervation Devices Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Renal Denervation Technologies Market by Technology (Microinfusion, Radiofrequency, Ultrasound), Cause (Diabetes, Heart Failure, Hypertension) - Forecast 2024-2030 - Product Image

Global Renal Denervation Technologies Market by Technology (Microinfusion, Radiofrequency, Ultrasound), Cause (Diabetes, Heart Failure, Hypertension) - Forecast 2024-2030

  • Report
  • 186 Pages
  • Global
From
Renal Denervation Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Renal Denervation Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 143 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.